Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$820M |
| 2 |
Palo Alto Networks
PANW
|
+$358M |
| 3 |
Visa
V
|
+$355M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Citigroup
C
|
+$325M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$722M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$356M |
| 3 |
Alibaba
BABA
|
+$345M |
| 4 |
EOG Resources
EOG
|
+$344M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.08% |
| 2 | Consumer Discretionary | 17.25% |
| 3 | Communication Services | 14.3% |
| 4 | Technology | 13.13% |
| 5 | Financials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALR
426
DELISTED
Alere Inc
ALR
| $21.7M | 0.02% |
+450,643
| New | +$23.4M |
|
427
Insmed
INSM
$22B
| $21.6M | 0.02% |
1,164,601
-7,395
| -0.6% | -$185K |
|
428
Five Below
FIVE
$12.1B
| $21.6M | 0.02% |
+643,040
| New | +$23.4M |
|
429
Q2 Holdings
QTWO
$3.7B
| $21.5M | 0.02% |
870,308
-66,421
| -7% | -$1.84M |
|
|
ISBC
430
DELISTED
Investors Bancorp, Inc.
ISBC
| $21.2M | 0.02% |
1,716,649
+1,143
| +0.1% | +$13.9K |
|
431
Prosperity Bancshares
PB
$8.97B
| $20.9M | 0.02% |
425,614
-99,132
| -19% | -$5.23M |
|
|
ANAC
432
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $20.5M | 0.02% |
174,546
-272,334
| -61% | -$35.6M |
|
433
Cogent Communications
CCOI
$663M
| $20.5M | 0.02% |
754,147
-81,547
| -10% | -$2.41M |
|
434
CALL
Travere Therapeutics
TVTX
$5.33B
| $20.3M | 0.02% |
+1,000,000
| New | +$29.6M |
|
435
Cheniere Energy
CQP
$31.5B
| $19.8M | 0.02% |
753,582
+77,557
| +11% | +$2.27M |
|
|
DYN.PRA
436
DELISTED
Dynegy Inc.
DYN.PRA
| $19.7M | 0.02% |
245,751
+1,398
| +0.6% | +$130K |
|
437
CNX Resources
CNX
$4.9B
| $19.3M | 0.02% |
2,368,123
-818,299
| -26% | -$10.2M |
|
438
Assembly Biosciences
ASMB
$516M
| $19.3M | 0.02% |
168,282
+859
| +0.5% | +$151K |
|
|
STKL
439
DELISTED
SunOpta
STKL
| $19.3M | 0.02% |
3,963,633
+1,361,090
| +52% | +$12.3M |
|
440
Wheaton Precious Metals
WPM
$51.5B
| $19.1M | 0.02% |
1,593,712
-91,630
| -5% | -$1.2M |
|
|
HMHC
441
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $19M | 0.02% |
936,205
+1,013
| +0.1% | +$24.2K |
|
442
Bloomin' Brands
BLMN
$759M
| $18.9M | 0.02% |
1,040,262
+55,143
| +6% | +$1.18M |
|
|
MKTO
443
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $18.8M | 0.02% |
660,608
-33,402
| -5% | -$943K |
|
|
RDC
444
DELISTED
Rowan Companies Plc
RDC
| $18.4M | 0.02% |
1,140,807
-79,072
| -6% | -$1.38M |
|
445
Prothena Corp
PRTA
$440M
| $18.4M | 0.02% |
404,765
+3,035
| +0.8% | +$177K |
|
|
TAHO
446
DELISTED
Tahoe Resources Inc
TAHO
| $18.2M | 0.02% |
2,346,972
+29,973
| +1% | +$267K |
|
447
B2Gold
BTG
$5.13B
| $18.1M | 0.02% |
17,100,168
+239,955
| +1% | +$292K |
|
448
CALL
Humana
HUM
$44B
| $17.9M | 0.02% |
100,000
| – | – |
|
449
Rocket Pharmaceuticals
RCKT
$351M
| $17.8M | 0.02% |
474,706
+106,092
| +29% | +$4.87M |
|
450
PTC Therapeutics
PTCT
$6.26B
| $17.8M | 0.02% |
+666,895
| New | +$28.5M |
|
Similar funds
Jennison Associates's Q3 2015 Portfolio in Review
As of Q3 2015, Jennison Associates held 813 positions worth $97.6B, down 11% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jennison Associates's Q3 2015 filing shows 84 new, 272 increased, 353 reduced and 92 closed positions. Its largest new stake was Palo Alto Networks: 12,124,434 shares worth $348M. The largest sale was Gilead Sciences, an estimated $722M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q3 2015 buy was Palo Alto Networks: 12,124,434 shares worth $348M.
- Jennison Associates added most to Alphabet (Google) Class C in Q3 2015, an estimated $820M increase.
- Jennison Associates's biggest Q3 2015 reduction was Gilead Sciences, cutting an estimated $722M.
- Jennison Associates fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $144M.
- Jennison Associates's ten largest holdings make up 24% of its $97.6B portfolio in Q3 2015.
- Jennison Associates opened 84 new positions and closed 92 in Q3 2015.
- Jennison Associates's portfolio value fell 11% quarter-over-quarter to $97.6B.
Based on Jennison Associates's 13F filing for Q3 2015, filed 6 Nov 2015.